Your SlideShare is downloading. ×
Implementing New Techniques, Technologies and Programs into an IVF Clinic - Ronny Janssens, Quality Manager, Centre for Reproductive Medicine at UZ, Brussels
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Implementing New Techniques, Technologies and Programs into an IVF Clinic - Ronny Janssens, Quality Manager, Centre for Reproductive Medicine at UZ, Brussels

815

Published on

Ronny Janssens, Quality Manager at UZB presented on implementing new techniques, technologies and programs into an IVF clinic

Ronny Janssens, Quality Manager at UZB presented on implementing new techniques, technologies and programs into an IVF clinic

Published in: Health & Medicine, Technology
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
815
On Slideshare
0
From Embeds
0
Number of Embeds
2
Actions
Shares
0
Downloads
34
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide
  • Practitioner evaluation of products is an extremely difficult task, in view of the enormous amount of both reliable and questionable product information available, variable interpretation of research projects, support of correct or incorrect information in the literature, the funding for research projects, the money that changes hands for some positive product recommendations, and the half-truths that are often used as "hype" to sell a product. On the positive, the products available today are far better than the products of even a few years ago. Practitioners need to seek information from a variety of trusted sources described in this article to make correct decisions. The sources of information identified in this article have not been prioritized. They vary in usefulness depending on the type of product, the geographic area in which you live, the speakers to whom you listen, your relationships with peers, manufacturers, retailers, and your own ability to sort out information. Use the most unbiased, up-to-date information available from the sources you find most appropriate for your practice, and remember, clinical success is the final test!
  • “Every procedure involving application to the human body should be defined as experimental until adequate scientific evidence is provided regarding its safety and efficacy”
  • “Every procedure involving application to the human body should be defined as experimental until adequate scientific evidence is provided regarding its safety and efficacy”
  • Complex process over several daysMultiple samples presentMultiple techniques (IVF/ICSI)Multiple manipulationsMultiple operatorsMultiple work stationsSize of cells/tissueHigh relative “value”
  • *** PLEASE ADD NOTES ***
  • Transcript

    • 1. Implementing new techniques, technologies and programs into an IVF clinic Ronny Janssens - Quality Manager
    • 2. Summary 1. 2. 3. 4. 5. 2 Why new technology? How to choose? How to implement into your practice? Examples @ UZB Conclusions 30-1-2014
    • 3. Why new technology?   3 Technological innovations are products of a society’s economy, a force for economic growth and are affected by a society's cultural traditions. How do science concepts, engineering skills, and applications of technology improve the results? 30-1-2014
    • 4. Sources of technological innovation (external)          4 Patients Industry Competitors Consultants Universities Publications, internet Exhibitions, fairs, seminars and conferences Certification/accreditation bodies Legislation 30-1-2014
    • 5. Sources of technological innovation (internal)  Own R & D  ICSI  Unexpected event  Witness  Change of work process  Day of transfer - Single step media 5 30-1-2014
    • 6. Obstacles to new technology       6 No access Lack of time (to learn, to plan, ...) No budget or high costs Technical/IT problems Intimidating – non expert status Too many strategies to try now – one more thing 30-1-2014
    • 7. Summary 1. 2. 3. 4. 5. 7 Why new technology? How to choose? How to implement into your practice? Examples @ UZB Conclusions 30-1-2014
    • 8. Harper et al. Hum. Reprod. 2012  8 “Every procedure involving application to the human body should be defined as experimental until adequate scientific evidence is provided regarding its safety and efficacy” 30-1-2014
    • 9. Definition of experimental procedures   9 The practice committe of the American Society for Reproductive Medicine. Fertil Steril, vol 99, 2013. Procedures ...will be considered experimental or investigational until the published medical evicence regarding their risks, benefits, and overall safety and efficacy is sufficient to regard them as established medical practice. Relevant medical evidence can derive only from appropriately designed, peerreviewed, published studies performed by several independent investigators, including a description of materials and methods sufficient to assess their scientific validity and to allow independent verification. 30-1-2014
    • 10. Ask yourself what is...  Benefit?  To patient  To service  Safety?  Has it been tested?  Is it safe?   Where is the evidence? Efficiency?  Does it work in your service?  Cost effective? 10 30-1-2014
    • 11. What is the right equipment?   Define required performance characteristics Review functionality  Does it conform?  Is it easy to use?  Extra features?    11 Analyze risks Appropriate support? Employees’ motivation? 30-1-2014
    • 12. What is the right equipment/procedure?  Use available information  Literature  External experts (universities, research laboratories...)  Discussion boards  Conferences, workshops  12 Analyze with data 30-1-2014
    • 13. Where is the evidence?  Evidence based medicine: “Sackett: Integrating individual expertise with the best available clinical evidence from systematic research.”  Archie Cochrane Founded in 1993 in the United Kingdom Cochrane Database of Systematic Reviews 13 30-1-2014
    • 14. Assisted reproductive technology: an overview of Cochrane Reviews Farquhart et al 2013  Effective interventions  Low oxygen concentration for embryo culture  SET  US guided ET  Promising (more evidence needed)  AH  Brief co-incubation of sperm for IVF  Possibly ineffective  IMSI  Ineffective  PGS  No conclusion possible  ICSI vs IVF for non-male infertility 14 30-1-2014
    • 15. Be objective!  Recombinant vs. Urinary gonadotrophins  No difference, known since mid 1990s “It is obvious why 7339 patients were included in redundant trials: industry funding” 15 30-1-2014
    • 16. Take home message  Does new technology increase productivity?  Focus on results, not technology  Be objective  Is there enough evidence?  Be aware of external pressure  16 Do you really need it? 30-1-2014
    • 17. Summary 1. 2. 3. Why new technology? How to choose? How to implement into your practice?  Validation  Staff training 4. 5. 17 Examples @ UZB Conclusions 30-1-2014
    • 18. PDCA cycle - Implementation in practice   Plan Do: Installation    Installation qualification  Test phase  Real time monitoring?  Check: Validation  Operational verification  NC?  18 Act Plan Do: Integration in work flow  SOP  QC/QA  Staff training  Check  Equipment failures  complaints  Act 30-1-2014
    • 19. ISO 15189  5.5.1.1 Validation of examination procedures  The laboratory shall only use examination procedures that have been validated as suitable for their intended use.  The validation shall be as extensive as is necessary and confirm, through the provision of objective evidence (in the form of performance characteristics), that the specific requirements (in the form of performance specifications ) for the intented use of the examination have been fulfilled 19 30-1-2014
    • 20. ISO 15189  5.5.1.1 Note 2 The means to be used for the determination of the performance characteristics of a procedure may be one of or a combination of the following: a) b) c) d) e) f) g) h) 20 Testing of calibration or reference measurement standards, or using reference measurement procedures; Internal quality control data; Use of patient samples with properties defined for the examinand, stability, and homogeneity; Comparison of results achieved with other methods; Inter laboratory comparisons; Systematic assessment of the factors influencing the results; Presence of carryover of material from a preceding high concentration sample, when applicable, and Presence of interferences or non-specificity that may be caused by, for example, metabolic or endogenous substances in the sample 30-1-2014
    • 21. Validation of ART process 21 30-1-2014
    • 22. Procedures – documents SOPs • • • As primary training resources To control process details Standard layout Forms • Data collection Process control Patienten ID verification Operator ID & witnessing Materials logging • Mentality change: from oral to written culture • • • • 22 30-1-2014
    • 23. Staff Who – What – When? Responsibility  Functions  Job descriptions  Task assignments  23 Training 30-1-2014
    • 24. Training plan 1. 2. 3. Observation Work under supervision Fully qualified Objective measurable criteria ! (>70% fertilisation - ICSI) 4. 24 Documented 30-1-2014
    • 25. Summary 1. 2. 3. 4. Why new technology? How to choose? How to implement into your practice? Examples @ UZB     5. 25 PGD/PGS IMSI Time lapse Witness Conclusions 30-1-2014
    • 26. New technologies @ UZ Brussel  Not implemented      Coculture PGS Spermatid injection PICSI Integrated workstations   Vitrosafe Ac-tive  Embryoglue  Time lapse incubators   Biostation Embryoscope  IMSI  LAISS 26  Implemented            ICSI Extended culture PGD Oocyte imaging Laser Dry incubators RFID (Witnesss) Desktopincubators (G-185) Blastocyst vitrification Embryo vitrification Oocyte vitrification 30-1-2014
    • 27. PGD/PGS @ UZB 2/93 3/96 5/98 6/98 11/98 6/99 Decompaction media First PGD Aspiration of blastomeres Sequential media Acid Tyrode Laser zona drilling
    • 28. Comparison laser with Acid Tyrode   28 Comparison of the results of human embryo biopsy and outcome of PGD after zona drilling using acid Tyrode medium or a laser. Joris, H., De Vos, A., Janssens, R., Devroey, P., Liebaers, I., and Van Steirteghem, A. Hum. Reprod. 2003.  The use of laser in cases of PGD is an easier procedure and results more intact blastomers in comparison with using acid Tyrode medium.Since similar pregnancy rates are obtained ,it is adventageous to use laser for zona drilling Laser confers less embryo exposure than acid tyrode for embryo biopsy in preimplantation genetic diagnosis cycles: a randomized study. Geber et al. Reprod Biol Endocrinol. 2011 30-1-2014
    • 29. PGS by FISH at cleavage stage is not effective in improving live birth delivery rate per cycle “This RCT provides no arguments in favour of PGD-AS for improving clinical outcome per initiated cycle in patients with AMA when there are no restrictions in the number of embryos to be transferred”   29 Confirmed by Mastenbroeck et al., 2007 Example of introduction into clinical practice without evidence 30-1-2014
    • 30. IMSI    30 Bartoov et al. 2001 Bartoov et coll, 2002 Bartoov et coll, 2003 N Engl J Med, vol. 345, N°14 J. Andrology 23:1-8 Fertil.steril.80:1413-1419 30-1-2014
    • 31. HOW DOES A GOOD SPERM LOOKS LIKE? vacuoles „Standard Image“ ICSI 31 30-1-2014
    • 32. Intracytoplasmic Morphologically-selected Sperm Injection (IMSI) 32 30-1-2014
    • 33.    33 Regular (ICSI) versus ultra-high magnification (IMSI) sperm selection for assisted reproduction Teixeira DM, Barbosa MAP, Ferriani RA, Navarro PA, Raine-Fenning N, Nastri CO, Martins WP, July 25, 2013 “We concluded that the current evidence does not support using IMSI: there is no evidence of benefit for live birth and miscarriage, we are very uncertain of the beneficial effect of IMSI in clinical pregnancy, and there is no evidence of the effect of this intervention on congenital abnormalities“ 30-1-2014
    • 34. IMSI “It is noteworthy that more prospective randomized trials are required to confirm the superiority of IMSI over conventional ICSI and to identify the causes of infertility that could benefit from the IMSI procedure.” 34 30-1-2014
    • 35. IMSI: conclusion    Complex technology Learning curve Risks  Cooling  Exposure to ambiant atmosphere    35 Expensive Bias? No evidence yet 30-1-2014
    • 36. IMSI @ UZB  Benifit No  To patient?  To service?  Safety? Yes  Has it been tested?  Is it safe?   Where is the evidence? Efficiency No  Does it work in your service?  Cost effective? 36 30-1-2014
    • 37. Time lapse imaging  Evidence?  Cochran: 0  RCT: 1  Kirkegaard et al. Hum Reprod 2013  Pubmed: 14 references form 1 group  External pressure?  “Further randomized prospective studies are being developed at the moment to evaluate and confirm the power of embryo selection by time-lapse systems 37 30-1-2014
    • 38. Time Lapse Systems @ UZB  Embryoscope (2010)  Validation  RCT (?)  Conclusion: research only  Primo Vision (-)  performance characteristics ?  MIRI TL incubator (2013)  Prototype  Validation in 2014    38 Incubator Culture coin Imaging 30-1-2014
    • 39. Witness @t UZ Brussel 39 30-1-2014
    • 40. IVF = Living in the danger zone!    Two sources of biological material ( Donor/acceptor cycles (X + Y = Z) Complex process over several days + = → ) DO NOT MAKE A MISTAKE! 40 30-1-2014
    • 41. Identification errors   How often do you make mistakes?  41 Experience is the name everyone gives to their mistakes (Oscar Wilde,1854 - 1900) When will it happen in your lab? 30-1-2014
    • 42. ISO15189   Use only validated methods Risk analysis R = P x E X C = 1 x 6 x 7 = 42  P = unlikely but possible  E = daily  C = severe R ≤ 20 20 < R ≤ 70 70 < R ≤ 200 200 < R ≤ 400 R > 400 42 acceptable very low risk, acceptable needs attention action needed immediate improvement required STOP 30-1-2014
    • 43. Identification systems in IVF 43 30-1-2014
    • 44. Barcode identification  HFEA risk assessment  Light and effect on gametes and embryos  Errors can occur in the printed barcode label  Barcode scanning can interrupt workflow processes  Possibility of circumvention  Novo et al., HR Vol 29, 2014  “it only allows the identification and traceability of oocytes destined for ICSI and embryos. Thus, the traceability of all reproductive samples (oocytes destined for IVF and sperm) is not yet ensured” 44 30-1-2014
    • 45. 2011: Integration into Clinical Practice  Hardware: work area readers, PCs, monitors      Ward: 2 admin readers Egg collection and transfer: 2 ID card readers Embryolab: 7 stereomicroscopes Semen lab: 3 semen prep antennas Software  Define witness flow chart  Interface with hospital system    45 SOP Training (2 days for administrators + in-house sessions) Validation (20 cases with simultaneous manual witnessing) 30-1-2014
    • 46. Witness at UZ Brussels anno 2014  Administration   Diagnostic semen lab   2 x 7 stereomicroscopes Embro replacement  46 1 sperm prep workstation 3 stereomicroscopes Embryology lab 1 and 2   2 ID card readers Infectious lab    7 sperm prep workstations Eggcollection   3 admin readers Therapeutic semen lab   2 admin readers Insemination rooms   2 admin readers 2 ID card readers 30-1-2014
    • 47. IVF Witness: employees’ motivation  Before: Anxiety  Less flexible  Novel technology  Changes in working habits 47  After: Optimism  Safe  Easy to adapt  Increased confidence 30-1-2014
    • 48. Summary 1. 2. 3. 4. 5. 48 Why new technology? How to choose? How to implement into your practice? Examples @ UZB Conclusions 30-1-2014
    • 49. Conclusions    Do you really need the new technology? Choose the right equipment Focus on results, not technology  Be objective, look for evidence   Does it work in your lab? Validate  Documentation  Staff training 49 30-1-2014
    • 50. For something completely different... 50 30-1-2014
    • 51. 51 30-1-2014
    • 52. Thank you!

    ×